Charles Schwab Investment Management Inc. Raises Position in Simulations Plus, Inc. (NASDAQ:SLP)

Charles Schwab Investment Management Inc. increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 143,253 shares of the technology company’s stock after purchasing an additional 6,418 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Simulations Plus were worth $3,995,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of SLP. Jones Financial Companies Lllp raised its stake in shares of Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after buying an additional 427 shares during the period. Quantbot Technologies LP bought a new stake in Simulations Plus in the 3rd quarter valued at about $59,000. US Bancorp DE raised its stake in Simulations Plus by 14.3% in the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock valued at $159,000 after acquiring an additional 713 shares during the period. Pitcairn Co. lifted its holdings in Simulations Plus by 9.1% during the third quarter. Pitcairn Co. now owns 6,599 shares of the technology company’s stock valued at $211,000 after purchasing an additional 549 shares during the last quarter. Finally, Olympiad Research LP bought a new position in Simulations Plus during the fourth quarter worth about $211,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on SLP shares. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. KeyCorp lifted their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $49.40.

Simulations Plus Stock Down 2.9 %

SLP stock opened at $24.00 on Thursday. Simulations Plus, Inc. has a twelve month low of $23.73 and a twelve month high of $51.22. The firm has a market capitalization of $482.21 million, a PE ratio of 60.00 and a beta of 0.89. The stock has a 50-day simple moving average of $31.03 and a two-hundred day simple moving average of $30.68.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the sale, the director now owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 19.40% of the stock is owned by corporate insiders.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.